Epoch Investment Partners’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $524K | Sell |
16,610
-27,574
| -62% | -$869K | ﹤0.01% | 265 |
|
|
2025
Q1 | $1.45M | Sell |
44,184
-41,507
| -48% | -$1.36M | 0.01% | 234 |
|
|
2024
Q4 | $3.1M | Buy |
85,691
+31,957
| +59% | +$1.16M | 0.02% | 218 |
|
|
2024
Q3 | $1.68M | Buy |
53,734
+17,878
| +50% | +$557K | 0.01% | 270 |
|
|
2024
Q2 | $959K | Sell |
35,856
-166,411
| -82% | -$4.45M | ﹤0.01% | 312 |
|
|
2024
Q1 | $6.9M | Sell |
202,267
-144,069
| -42% | -$4.91M | 0.03% | 264 |
|
|
2023
Q4 | $10M | Sell |
346,336
-41,317
| -11% | -$1.2M | 0.05% | 262 |
|
|
2023
Q3 | $10.7M | Sell |
387,653
-88,386
| -19% | -$2.44M | 0.07% | 252 |
|
|
2023
Q2 | $14.3M | Buy |
476,039
+1,216
| +0.3% | +$36.6K | 0.08% | 223 |
|
|
2023
Q1 | $17.2M | Buy |
474,823
+520
| +0.1% | +$18.8K | 0.1% | 208 |
|
|
2022
Q4 | $16.9M | Sell |
474,303
-16,937
| -3% | -$604K | 0.1% | 215 |
|
|
2022
Q3 | $16.6M | Buy |
491,240
+15,199
| +3% | +$514K | 0.11% | 207 |
|
|
2022
Q2 | $13.8M | Sell |
476,041
-19,074
| -4% | -$552K | 0.08% | 234 |
|
|
2022
Q1 | $16M | Buy |
495,115
+36,960
| +8% | +$1.19M | 0.08% | 234 |
|
|
2021
Q4 | $13.4M | Buy |
458,155
+68,750
| +18% | +$2M | 0.07% | 248 |
|
|
2021
Q3 | $10.4M | Buy |
+389,405
| New | +$10.4M | 0.06% | 261 |
|